Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Diamondback Energy Inc (NASDAQ: FANG) rose significantly of late. FANG’s current Value Trend Rating is A and the prior Rating […]
Xenon Pharmaceuticals Inc (NASDAQ: XENE) has reported E.P.S. of $-0.64 for its fourth fiscal quarter (ending December 31) versus $-0.57 for the same period a year ago. Relative to the consensus estimate of $-0.76, this […]
Vericel Corp (NASDAQ: VCEL) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.27 versus $0.13 for the same period a year ago — an increase of 108%. This result exceeded the […]
Extremely significant negative changes in Schnitzer Steel Industries Inc (NASDAQ: SCHN) investment behavior have recently occurred: negative upside/downside volume developed, and the stock fell on very heavy volume. Recent important negative changes in fundamentals have […]
On 2/29/24, Revance Therapeutics Inc (NASDAQ: RVNC) stock enjoyed a major increase of 26.1%, closing at $7.14. Moreover, this advance was accompanied by exceptionally high trading volume at 437% of normal. Relative to the market […]
On 2/29/24, Natera Inc (NASDAQ: NTRA) stock enjoyed a major increase of 13.0%, closing at $86.49. Moreover, exceptionally high trading volume at 274% of normal accompanied the advance. Relative to the market the stock has […]
Middlesex Water Co (NASDAQ: MSEX) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.32 versus $0.40 for the same period a year ago — a decline of -20%. Relative to the […]
MannKind Corp (NASDAQ: MNKD) has recently enjoyed extremely meaningful positive changes in investment behavior: positive upside/downside volume developed, its shorter term price trend turned up, and the stock rose on very heavy volume. MannKind Corp […]
On 2/29/24, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) stock suffered a major decline of -37.6%, closing at $9.43. Moreover, trading volume in this decline was exceptionally high at 835% of normal. Relative to the market the […]
Integra LifeSciences Holdings Co (NASDAQ: IART). Extremely significant negative changes in investment behavior have recently occurred: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research